HJ Science Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Revenue	14.03	12.98	1.8
Other Revenue	0.09	0.09	0.77
Revenue	14.12	13.07	2.57
Revenue Growth	-	407.77%	-
Gross Profit	14.12	13.07	2.57
Selling, General & Admin	40.14	28.29	12.64
Research & Development	115.52	110.18	74.97
Operating Expenses	155.66	138.47	87.61
Operating Income	-141.54	-125.4	-85.03
Interest Expense	-0.37	-0.13	-0.05
Interest & Investment Income	0.32	0.09	2.08
Earnings From Equity Investments	-0.16	-0.16	-0.24
Other Non Operating Income (Expenses)	-18.67	-16.03	-124.73
EBT Excluding Unusual Items	-161.87	-141.63	-207.97
Gain (Loss) on Sale of Investments	6.54	6.54	5.65
Gain (Loss) on Sale of Assets	-0.28	0	-
Pretax Income	-155.61	-135.08	-202.32
Income Tax Expense	0	0	-
Net Income	-155.61	-135.08	-202.32
Net Income to Common	-155.61	-135.08	-202.32
Net Income Growth	-	-	-
Shares Outstanding (Basic)	60	59	40
Shares Outstanding (Diluted)	60	59	40
Shares Change	-	50.01%	-
EPS (Basic)	-2.58	-2.28	-5.12
EPS (Diluted)	-2.58	-2.28	-5.12
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-90.88	-90.95	-79.67
Free Cash Flow Per Share	-1.51	-1.53	-2.02
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-1002.24%	-959.44%	-3303.57%
Profit Margin	-1101.92%	-1033.54%	-7860.02%
Free Cash Flow Margin	-643.53%	-695.85%	-3095.26%
EBITDA	-139.81	-123.46	-82.77
D&A For EBITDA	1.73	1.94	2.26
EBIT	-141.54	-125.4	-85.03